MEDIGENA
ActiveSummary
MEDIGENA has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,000 and a net result of €14,379. Equity is shrinking by about 2.9% per year across the filed financial years. Its solvency ranks better than 11% of 20,558 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
09-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 9 days late
2025
22-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 22 days late
2024
31-12
Financial
Highest result from 2023 to 2025net €54,065 ▲276%
Operating result €70,785, net result €54,065, both a record.
24-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.